Cellectar Biosciences

NASDAQ: CLRB
Nasdaq Stock Market
Healthcare Biotechnology
Global Rank
#37452
Country Rank
#4763
Market Cap
15.86 M
Price
0.292
Change (%)
20.16%
Volume
3.84 M

Cellectar Biosciences (NASDAQ: CLRB) Stock Split History

Date Split Ratio Multiple Cumulative multiple Type
06/24/2025 1:30 x0.03333334 x0.00000001089966 Reverse
07/22/2022 1:10 x0.1 x0.0000003269898 Reverse
07/17/2018 1:10 x0.1 x0.000003269898 Reverse
03/07/2016 1:10 x0.1 x0.00003269898 Reverse
06/16/2014 1:20 x0.05 x0.0003269897 Reverse
04/11/2011 1:152.91 x0.006539795 x0.006539795 Reverse

Frequently Asked Questions

  • How much would Cellectar Biosciences stock be worth if it never split?
    If Cellectar Biosciences (stock symbol: NASDAQ: CLRB) had never undergone any stock splits, its price per share today would be approximately 0.00 USD. This calculation reflects the cumulative effect of all splits, including the most recent split (ratio: 1-for-30) that occurred on 06/24/2025.
  • Cellectar Biosciences (stock symbol: NASDAQ: CLRB) has undergone a total of six stock splits. The most recent split occurred on 06/24/2025. One share bought prior to the first split on 04/11/2011 would now equal 0.00 shares.
  • Cellectar Biosciences (stock symbol: NASDAQ: CLRB) has undergone six stock splits in its history. The most recent split, a 1-for-152.91 split, occurred on 06/24/2025. While future splits are not guaranteed, significant increases in stock price could prompt consideration for another split.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.